Li Ren - Chimeric Therapeutics VP Operations
Insider
Li Ren is VP Operations of Chimeric Therapeutics Limited
| Phone | 61 3 9824 5254 |
| Web | https://www.chimerictherapeutics.com |
Chimeric Therapeutics Management Efficiency
The company has return on total asset
(ROA) of
(0.2552) % which means that it has lost $0.2552 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.6255) %, meaning that it generated substantial loss on money invested by shareholders. Chimeric Therapeutics' management efficiency ratios could be used to measure how well Chimeric Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Similar Executives
Chimeric Therapeutics Limited [CHMMF] is a
Pink Sheet which is traded between brokers over the counter.
Management Performance
Chimeric Therapeutics Leadership Team
Elected by the shareholders, the Chimeric Therapeutics' board of directors comprises two types of representatives: Chimeric Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chimeric. The board's role is to monitor Chimeric Therapeutics' management team and ensure that shareholders' interests are well served. Chimeric Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chimeric Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Chimeric Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Chimeric Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Chimeric Pink Sheet
Chimeric Therapeutics financial ratios help investors to determine whether Chimeric Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chimeric with respect to the benefits of owning Chimeric Therapeutics security.